open access
Dutasteride mesotherapy in the treatment of androgenetic alopecia
, 2
Affiliations- Department of Rheumatology and Internal Medicine, Jan Mikulicz-Radecki University Clinical Hospital in Wroclaw, Poland
- Department of Nephrology and Transplant Medicine, Jan Mikulicz-Radecki University Clinical Hospital in Wroclaw, Poland
open access
Abstract
Abstract
Keywords
androgenetic alopecia, dutasteride, mesotherapy
About this articleTitle
Dutasteride mesotherapy in the treatment of androgenetic alopecia
Journal
Issue
Article type
Letter to the Editor
Pages
129-131
Published online
2023-08-22
Page views
181
Article views/downloads
568
DOI
Bibliographic record
Forum Dermatologicum 2023;9(3):129-131.
Keywords
androgenetic alopecia
dutasteride
mesotherapy
Authors
Jakub Kobiałka
Ugo Giordano
References (12)- Reguero Del Cura L, De Quintana Sancho A, Rubio Lombraña M, et al. Two cases of paradoxical nonscarring alopecia after mesotherapy with dutasteride. Skin Appendage Disord. 2022; 8(1): 46–48.
- Herz-Ruelas ME, Álvarez-Villalobos NA, Millán-Alanís JM, et al. Efficacy of intralesional and oral dutasteride in the treatment of androgenetic alopecia: a systematic review. Skin Appendage Disord. 2020; 6(6): 338–345.
- Almohanna HM, Perper M, Tosti A. Safety concerns when using novel medications to treat alopecia. Expert Opin Drug Saf. 2018; 17(11): 1115–1128.
- Moftah N, Mubarak R, Abdelghani R. Clinical, trichoscopic, and folliscopic identification of the impact of metabolic syndrome on the response to intradermal dutasteride 0.02% injection in patients with female pattern hair loss: a prospective cohort study. J Dermatolog Treat. 2021; 32(7): 827–836.
- Alsalhi W, Alalola A, Randolph M, et al. Novel drug delivery approaches for the management of hair loss. Expert Opin Drug Deliv. 2020; 17(3): 287–295.
- Vineetha Reddy M, Jyothi M, Venkatesh D, et al. Mesotherapy in face. International J Res Engineering, Sci Manag. 2019; 2(10): 822–829.
- Abdallah MA, El-Zawahry KA, Besar H. Mesotherapy using dutasteride-containing solution in male pattern hair loss: A controlled pilot study. J Pan Arab Leag Dermatol. 2009; 20: 137–145.
- Saceda-Corralo D, Rodrigues-Barata AR, Vañó-Galván S, et al. Mesotherapy with dutasteride in the treatment of androgenetic alopecia. Int J Trichology. 2017; 9(3): 143–145.
- Sobhy N, Aly H, Shafee AEl, et al. Evaluation of the effect of injection of dutasteride as mesotherapeutic tool in treatment of androgenetic alopecia in males. Our Dermatology Online. 2013; 4(1): 40–45.
- Moftah N, Moftah N, Abd-Elaziz G, et al. Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation. J Eur Acad Dermatol Venereol. 2013; 27(6): 686–693.
- Saceda-Corralo D, Moustafa F, Moreno-Arrones Ó, et al. Mesotherapy with dutasteride for androgenetic alopecia: a retrospective study in real clinical practice. J Drugs Dermatol. 2022; 21(7): 742–747.
- Magdaleno-Tapial J, Valenzuela-Oñate C, García-Legaz-Martínez M, et al. Angioedema-like contact dermatitis caused by mesotherapy with dutasteride. Contact Dermatitis. 2020; 83(3): 246–247.
